These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29084047)

  • 1. Infection by HTLV-1 Is Associated With High Levels of Proinflammatory Cytokines in HIV-HCV-Coinfected Patients.
    Brites C; Abrahão M; Bozza P; Netto EM; Lyra A; Bahia F
    J Acquir Immune Defic Syndr; 2018 Feb; 77(2):230-234. PubMed ID: 29084047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus.
    Bahia F; Novais V; Evans J; Le Marchand C; Netto E; Page K; Brites C
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 3(0 3):S202-7. PubMed ID: 21857319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry.
    Bischoff J; Mauss S; Cordes C; Lutz T; Scholten S; Cornberg M; Manns MP; Baumgarten A; Rockstroh JK
    HIV Clin Trials; 2018 Dec; 19(6):225-234. PubMed ID: 30890063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reasons to include the serology of human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in the clinical follow-up of patients with viral hepatitis B and C in Brazil.
    Campos KR; Alves FA; Lemos MF; Moreira RC; Marcusso RMN; Caterino-de-Araujo A
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008245. PubMed ID: 32453768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil.
    Le Marchand C; Bahia F; Page K; Brites C
    Braz J Infect Dis; 2015; 19(5):486-91. PubMed ID: 26254690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
    Griesbeck M; Valantin MA; Lacombe K; Samri-Hassimi A; Bottero J; Blanc C; Sbihi Z; Zoorob R; Katlama C; Guiguet M; Altfeld M; Autran B;
    AIDS; 2017 Jun; 31(9):1223-1234. PubMed ID: 28492391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response predictors and clinical benefits of hepatitis C retreatment with pegylated interferon and ribavirin in HIV/HCV coinfection.
    Peribañez-Gonzalez M; da Silva MH; Vilar FC; Seixas-Santos Nastri AC; Ferreira PA; Focaccia R; Mendes Correa MC
    Ann Hepatol; 2013; 12(2):228-35. PubMed ID: 23396734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
    Kerzerho J; McIlvaine EJ; Anthony P; Mack WJ; Wang CH; Frederick T; Operskalski E; Chen Z; Al-Harthi L; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Akbari O; Golub ET; Sharp GB; Kovacs A
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):172-80. PubMed ID: 26761519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in a Cohort of HIV-Infected Patients Single- or Co-Infected with HTLV-1, HTLV-2, and/or HCV: A Cross-Sectional, Observational Study.
    Caterino-de-Araujo A; Campos KR; Oliveira LMS; Rigato PO
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients.
    Fernández-Rodríguez A; Rallón N; Berenguer J; Jiménez-Sousa MA; Cosín J; Guzmán-Fulgencio M; Restrepo C; Lopez JC; García-Álvarez M; Miralles P; Soriano V; Benito JM; Resino S
    AIDS; 2013 Jan; 27(2):163-73. PubMed ID: 23135173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men.
    Aebi-Popp K; Wandeler G; Salazar-Vizcaya L; Metzner K; Stöckle M; Cavassini M; Hoffmann M; Lüthi A; Suter F; Bernasconi E; Fehr J; Furrer H; Rauch A;
    HIV Med; 2018 Jul; 19(6):420-425. PubMed ID: 29573533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of co-infections by HCV and HBV among Brazilian patients infected by HIV-1 and/or HTLV-1.
    Moreira M; Ramos A; Netto EM; Brites C
    Braz J Infect Dis; 2013; 17(6):661-6. PubMed ID: 24029434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: Reduced Cell-Associated HTLV-2 DNA in Antiretroviral Treated HIV-1-HCV-Coinfected Patients Who Either Received Interferon-α/Ribavirin-Based Hepatitis C Therapy or Had Spontaneous HCV RNA Clearance.
    Abad-Fernández M; Dronda F; Moreno A; Casado JL; Pérez-Elías MJ; Quereda C; Moreno S; Vallejo A
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):286-90. PubMed ID: 26181704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients.
    López-Cortés LF; Trujillo-Rodríguez M; Báez-Palomo A; Benmarzouk-Hidalgo OJ; Dominguez-Molina B; Milanés-Guisado Y; Espinosa N; Viciana P; Gutiérrez-Valencia A
    J Infect Dis; 2018 Jul; 218(4):624-632. PubMed ID: 29986086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTLV-2 Enhances CD8
    Abad-Fernández M; Hernández-Walias FJ; Ruiz de León MJ; Vivancos MJ; Pérez-Elías MJ; Moreno A; Casado JL; Quereda C; Dronda F; Moreno S; Vallejo A
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCV/HTLV coinfection: Does HTLV-1 interfere in the natural history of HCV-related diseases?
    Silva MC; Silva CA; Machado GU; Atta A; M Freire S; Carvalho E; Schinoni MI; Paraná R
    J Med Virol; 2016 Nov; 88(11):1967-72. PubMed ID: 27027482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy.
    Abad-Fernández M; Moreno A; Dronda F; del Campo S; Quereda C; Casado JL; Pérez-Elías MJ; Moreno S; Vallejo A
    AIDS; 2015 Feb; 29(4):401-9. PubMed ID: 25565497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Hepatitis C virus coinfection on immune reconstitution in HIV subjects.
    Badano MN; Parodi C; Aloisi N; Corti M; Elizalde de Bracco MM; Baré P
    Med Microbiol Immunol; 2019 Dec; 208(6):747-756. PubMed ID: 31147782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy.
    Kang F; Chen W; Zhang X; Nie W; Fu J; Xu X; Zhao P; Zhang X; Li W; Wang FS; Zhang Z; Zhao M
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):135-42. PubMed ID: 23075912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.